PRS55 - COST-EFFECTIVENESS OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA PATIENTS IN FRANCE
Autor: | Maunoury, F., Pribil, C., Aubier, M., Nachbaur, G., Doyle, S. |
---|---|
Zdroj: | In Value in Health October 2018 21 Supplement 3:S413-S413 |
Databáze: | ScienceDirect |
Externí odkaz: |